Severe pulmonary hemorrhage in patients with end-stage renal disease in antineutrophil cytoplasmic autoantibody-associated vasculitis

American Journal of the Medical Sciences

Volumn 337, Issue 6, 2009, Pages 411-414

  Chen, Min ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Antineutrophil cytoplasmic autoantibody; End stage renal disease; Pulmonary hemorrhage; Vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADOLESCENT; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUNG HEMORRHAGE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; OUTCOME ASSESSMENT; PLASMAPHERESIS; REMISSION; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; BLEEDING; CHRONIC KIDNEY FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG DISEASE; MIDDLE AGED; VASCULITIS;

ADOLESCENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMORRHAGE; HUMANS; KIDNEY FAILURE, CHRONIC; LUNG DISEASES; MALE; MIDDLE AGED; VASCULITIS;

EID: 67650215416     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181928d24     Document Type: Article

References (14)

1. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998;9:1258-1263 (Pubitemid 28283889)
2. Cohen BA, Clark WF. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy. Am J Kidney Dis 2000;36:914-924
3. Westman KW, Bygren PG, Olsson H, et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegeners granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998;9:842-852 (Pubitemid 28209094)
4. Schmitt WH, van der Woude FJ. Organ transplantation in the vasculitides. Curr Opin Rheumatol 2003;15:22-28
5. Weidanz F, Day CJ, Hewins P, et al. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis 2007;50:36-46. (Pubitemid 46962856)
6. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192 (Pubitemid 24065492)
7. Hellmich B, Flossmann O, Gross WL, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on ANCA-associated vasculitis. Ann Rheum Dis 2007;66:605-617 (Pubitemid 46707128)
8. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-678
9. Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods 1996;197:121-130
10. Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005;143:621-631 (Pubitemid 41552526)
11. Gera M, Griffin MD, Specks U, et al. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosuppression. Kidney Int 2007;71:1296-1301 (Pubitemid 46884256)
12. Haubitz M, Koch KM, Brunkhorst R. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis. Nephrol Dial Transplant 1998;13:1713-1718 (Pubitemid 28306800)
13. Chen M, Yu F, Zhang Y, et al. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine 2008;87:203-209
14. Chen M, Yu F, Zhao MH. Relapses in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: likely to begin with the same organ as initial onset. J Rheumatol 2008;35:448-450